针对蛋白异戊烯化治疗癌症。
Targeting protein prenylation for cancer therapy.
机构信息
Drug Discovery Department, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, USA.
出版信息
Nat Rev Cancer. 2011 Oct 24;11(11):775-91. doi: 10.1038/nrc3151.
Abstract
Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid post-translational modifications that are required for the transforming activity of many oncogenic proteins, including some RAS family members. This observation prompted the development of inhibitors of farnesyltransferase (FT) and geranylgeranyl-transferase 1 (GGT1) as potential anticancer drugs. In this Review, we discuss the mechanisms by which FT and GGT1 inhibitors (FTIs and GGTIs, respectively) affect signal transduction pathways, cell cycle progression, proliferation and cell survival. In contrast to their preclinical efficacy, only a small subset of patients responds to FTIs. Identifying tumours that depend on farnesylation for survival remains a challenge, and strategies to overcome this are discussed. One GGTI has recently entered the clinic, and the safety and efficacy of GGTIs await results from clinical trials.
摘要
蛋白质法尼基化和香叶基化，统称为 prenylation，是脂质翻译后修饰，是许多致癌蛋白（包括一些 RAS 家族成员）转化活性所必需的。这一观察结果促使人们开发法尼基转移酶（FT）和香叶基转移酶 1（GGT1）抑制剂作为潜在的抗癌药物。在这篇综述中，我们讨论了 FT 和 GGT1 抑制剂（分别为 FTIs 和 GGTIs）如何影响信号转导途径、细胞周期进程、增殖和细胞存活的机制。与它们的临床前疗效相比，只有一小部分患者对 FTIs 有反应。确定依赖法尼基化来生存的肿瘤仍然是一个挑战，并且正在讨论克服这一挑战的策略。一种 GGTI 最近已进入临床，GGTIs 的安全性和疗效有待临床试验结果。
相似文献
1
Targeting protein prenylation for cancer therapy.针对蛋白异戊烯化治疗癌症。
Nat Rev Cancer. 2011 Oct 24;11(11):775-91. doi: 10.1038/nrc3151.
2
3
Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.法尼基转移酶和香叶基香叶基转移酶I抑制剂与癌症治疗：来自作用机制及从 bench 到 bedside 的转化研究的经验教训
Oncogene. 2000 Dec 27;19(56):6584-93. doi: 10.1038/sj.onc.1204146.
4
The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.法尼基转移酶抑制剂（FTI）SCH66336（洛那法尼）可抑制Rheb的法尼基化和mTOR信号传导。其在FTI增强紫杉烷和他莫昔芬抗肿瘤活性中的作用。
J Biol Chem. 2005 Sep 2;280(35):31101-8. doi: 10.1074/jbc.M503763200. Epub 2005 Jul 8.
5
[Development of farsenyl transferase inhibitors as anticancer agents].[法尼基转移酶抑制剂作为抗癌药物的研发]
Ann Pharm Fr. 2005 Jan;63(1):76-84. doi: 10.1016/s0003-4509(05)82254-0.
6
Evolving therapies: farnesyltransferase inhibitors.不断发展的疗法：法尼基转移酶抑制剂
Curr Oncol Rep. 2002 Jan;4(1):29-36. doi: 10.1007/s11912-002-0045-8.
7
Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues.法尼基转移酶和香叶基香叶基转移酶I抑制剂在癌症治疗中的应用：重要的作用机制及从实验台到临床的问题
Expert Opin Investig Drugs. 2000 Dec;9(12):2767-82. doi: 10.1517/13543784.9.12.2767.
8
Farnesylated proteins and cell cycle progression.法尼基化蛋白与细胞周期进程。
J Cell Biochem Suppl. 2001;Suppl 37:64-70. doi: 10.1002/jcb.10067.
9
Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells.哺乳动物细胞中的蛋白质法尼基化：法尼基转移酶抑制剂对癌细胞的影响。
Cell Mol Life Sci. 2001 Oct;58(11):1636-49. doi: 10.1007/PL00000802.
10
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.法尼基化抑制剂治疗髓系白血病的疗效
Leukemia. 2003 Aug;17(8):1482-98. doi: 10.1038/sj.leu.2403024.
引用本文的文献
1
Uncovering protein prenylation in Th1 cells: novel prenylation sites and insights into statin and farnesyltransferase inhibition.揭示Th1细胞中的蛋白质异戊二烯化：新的异戊二烯化位点以及对他汀类药物和法尼基转移酶抑制作用的见解
BMC Biol. 2025 Jul 31;23(1):233. doi: 10.1186/s12915-025-02345-1.
2
Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics.肿瘤微环境中的蛋白质脂化：酶学、信号通路与治疗学
Mol Cancer. 2025 May 7;24(1):138. doi: 10.1186/s12943-025-02309-7.
3
Design and Evaluation of Bivalent K-Ras Inhibitors That Target the CAAX Binding Site and the Acidic Surface of Farnesyltransferase and Geranylgeranyltransferase I.靶向法尼基转移酶和香叶基香叶基转移酶I的CAAX结合位点和酸性表面的二价K-Ras抑制剂的设计与评估。
Chemistry. 2025 May 14;31(27):e202500306. doi: 10.1002/chem.202500306. Epub 2025 Apr 28.
4
Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer.基于功能蛋白质组学对肺癌中细胞对法尼基转移酶抑制反应的研究。
iScience. 2025 Jan 21;28(2):111864. doi: 10.1016/j.isci.2025.111864. eCollection 2025 Feb 21.
5
Synthesis, Bioproduction and Bioactivity of Perillic Acid-A Review.紫苏酸的合成、生物生产及生物活性——综述
Molecules. 2025 Jan 24;30(3):528. doi: 10.3390/molecules30030528.
6
Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization.对固醇调节元件结合蛋白2（SREBP2）和甲羟戊酸途径的合成抑制作用可在体外和体内阻断横纹肌肉瘤的肿瘤生长，并促进化学增敏作用。
Mol Metab. 2025 Feb;92:102085. doi: 10.1016/j.molmet.2024.102085. Epub 2024 Dec 18.
7
An Alkyne-Containing Isoprenoid Analogue Based on a Farnesyl Diphosphate Scaffold Is a Biologically Functional Universal Probe for Proteomic Analysis.基于法尼基二磷酸支架的含炔类异戊二烯类似物是用于蛋白质组学分析的具有生物学功能的通用探针。
Biochemistry. 2025 Jan 7;64(1):138-155. doi: 10.1021/acs.biochem.4c00558. Epub 2024 Dec 9.
8
"Undruggable KRAS": druggable after all.“不可成药的KRAS”：终究是可成药的。
Genes Dev. 2025 Jan 7;39(1-2):132-162. doi: 10.1101/gad.352081.124.
9
FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer.FGTI-2734抑制ERK再激活以克服KRAS G12C肺癌中的索托拉西布耐药性。
J Thorac Oncol. 2025 Mar;20(3):331-344. doi: 10.1016/j.jtho.2024.11.022. Epub 2024 Nov 26.
10
Genetics and biology of pancreatic ductal adenocarcinoma.胰腺导管腺癌的遗传学与生物学
Genes Dev. 2025 Jan 7;39(1-2):36-63. doi: 10.1101/gad.351863.124.
本文引用的文献
1
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.法尼基转移酶和 Akt 抑制剂联合使用在乳腺癌细胞中具有协同作用，并导致 ErbB2 转基因小鼠的乳腺肿瘤显著消退。
Clin Cancer Res. 2011 May 1;17(9):2852-62. doi: 10.1158/1078-0432.CCR-10-2544.
2
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies.法尼基转移酶表达决定晚期恶性肿瘤患者对多西他赛-洛那法尼联合治疗的临床反应。
Cancer. 2011 Sep 1;117(17):4049-59. doi: 10.1002/cncr.26004. Epub 2011 Mar 1.
3
Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.磷酸化调节激酶（PRAK）介导的雷帕霉素靶蛋白（Rheb）失活对于能量耗竭诱导的 mTORC1 抑制是必需的。
Nat Cell Biol. 2011 Mar;13(3):263-72. doi: 10.1038/ncb2168. Epub 2011 Feb 20.
4
Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.评价炔基修饰的异戊二烯作为蛋白质类异戊二烯化的化学报告物。
Chem Biol Drug Des. 2010 Dec;76(6):460-71. doi: 10.1111/j.1747-0285.2010.01037.x. Epub 2010 Oct 11.
5
Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease.使香叶基香叶基转移酶I失活可减轻K-RAS诱导的骨髓增殖性疾病小鼠模型中的疾病表型。
Leukemia. 2011 Jan;25(1):186-9. doi: 10.1038/leu.2010.242. Epub 2010 Oct 26.
6
Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.异戊烯半胱氨酸羧甲基转移酶抑制诱导自噬依赖性细胞凋亡并损害肿瘤生长。
Oncogene. 2010 Sep 2;29(35):4959-70. doi: 10.1038/onc.2010.247. Epub 2010 Jul 12.
7
A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.K-Ras 癌基因与 Cdk4 的合成致死相互作用揭示了非小细胞肺癌的治疗策略。
Cancer Cell. 2010 Jul 13;18(1):63-73. doi: 10.1016/j.ccr.2010.05.025.
8
Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells.脑富集 Ras 同源物是法尼基转移酶抑制剂在非小细胞肺癌细胞中的关键靶标。
Cancer Lett. 2010 Nov 1;297(1):117-25. doi: 10.1016/j.canlet.2010.05.004.
9
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Akt 激活抑制剂 TCN-P 通过与 Akt 的 PH 结构域结合并阻止其募集到质膜上来抑制 Akt 磷酸化。
Cell Death Differ. 2010 Nov;17(11):1795-804. doi: 10.1038/cdd.2010.63. Epub 2010 May 21.
10
The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.法尼基转移酶抑制剂 LB42708 通过抑制 ras 依赖性有丝分裂原激活的蛋白激酶和磷脂酰肌醇 3-激酶/Akt 信号通路抑制血管内皮生长因子诱导的血管生成。
Mol Pharmacol. 2010 Jul;78(1):142-50. doi: 10.1124/mol.110.063586. Epub 2010 Apr 20.
Zotero 插件